InvestSMART

Intelligent Investor Australian Equity Growth Fund (Managed Fund) (ASX: IIGF) - Share Price and Research

- Current share price for IIGF : $3.160

Intelligent Investor Australian Equity Growth Fund (Managed Fund) (IIGF) is an Exchange Traded Fund - commonly known as an ETF. For more details about how ETFs work, feel free to check out our What is an ETF? overview. Intelligent Investor Australian Equity Growth Fund (Managed Fund) (IIGF) is an Exchange Traded Fund. The fund primarily invests in the securities of companies listed on the Australian Securities Exchange. The fund's portfolio will comprise 10 to 35 securities at any one time but will also have some exposure to cash.

General Information

Intelligent Investor Australian Equities Growth ETF
InvestSMART Funds Management Limited
Equity Australia Large Blend
S&P/ASX 200 TR AUD
star
star (as at 31 Aug 2025)
Investment Fund
5 Oct 2020
$97.94 million (as at 22 Sep 2025)
$3.1519 (as at 22 Sep 2025)
$3.1519 (as at 22 Sep 2025)

IIGF ETF performance (31 Aug 2025)

NOTE : returns for periods greater than 1 year are annualised
  1 Month % 3 Month % 6 Month % 1 Year % p.a. 2 Year % p.a. 3 Year % p.a. 5 Year % p.a. 10 Year % p.a.
Total return 2.62 10.69 11.69 8.47 8.16 5.1 - -
Growth return 2.62 9.61 10.6 6.41 6.52 1.9 - -
Income return (Yield) 0 1.08 1.09 2.06 1.64 3.2 - -

Market index (S&P/ASX 200 TR AUD)
Total return 3.1 7.03 11.65 14.74 14.82 13.04 12.32 9.87

Asset Allocation (31 Aug 2025)

Australian Equities 66.28%
International Equities 24.06%
Cash 9.66%
Property & Infrastructure 0%
Fixed Interest 0%
Alternatives 0%
Asset Allocation

Objectives and Strategy

The primary objective of the Fund is to invest in a portfolio of high quality, undervalued listed Australian stocks with superior financial metrics and competitive advantages to outperform the S&P/ASX 200 Accumulation Index p.a. by 2% p.a. over five year rolling periods with minimal turnover to allow returns to compound in a favourable tax environment.
Portfolio constituents will be a mix of high growth stocks where the managers believe earnings will grow faster for longer than the market expects, and stocks whose slower and more stable earnings growth have been excessively discounted for temporary reasons resulting in a depressed valuation.

Offer information

MER 0.97% (as at 30 Sep 2024)
Indirect Cost Ratio (ICR) 0.97% (as at 30 Jun 2022)
Performance fee (not included in ICR) 0
Minimum initial investment

Top 10 holdings (as at 30 Jun 2025)

Holding Type % of Portfolio
ResMed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh Equity 6.96%
Login now to view the complete list of holdings.

Fund data sourced from Morningstar. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only. Whilst every care has been taken in producing these numbers, neither Morningstar nor InvestSMART can make any guarantees around the complete accuracy of these figures. Should you decide to change investments, please read all relevant disclosure documents including the Product Disclosure Statements and if required, you may consider speaking to a financial professional for further guidance. A tax event may be realised as a result of switching investments. Past performance is not a reliable indicator of future performance.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.